These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 10030500)

  • 21. FDA proposes mechanism for disseminating information about off-label uses.
    Am J Health Syst Pharm; 1998 Jul; 55(14):1449-50. PubMed ID: 9676288
    [No Abstract]   [Full Text] [Related]  

  • 22. Changes at FDA may speed drug approval process and increase off-label use.
    Reh M
    J Natl Cancer Inst; 1998 Jun; 90(11):805-7. PubMed ID: 9625166
    [No Abstract]   [Full Text] [Related]  

  • 23. A defense of the learned intermediary doctrine.
    Goetz RB; Growdon KR
    Food Drug Law J; 2008; 63(2):421-38. PubMed ID: 18561470
    [No Abstract]   [Full Text] [Related]  

  • 24. Black box warnings in prescription drug labeling: results of a survey of 206 drugs.
    Beach JE; Faich GA; Bormel FG; Sasinowski FJ
    Food Drug Law J; 1998; 53(3):403-11. PubMed ID: 10346718
    [No Abstract]   [Full Text] [Related]  

  • 25. FDA to require pediatric studies for drugs commonly used in children.
    Miller JL
    Am J Health Syst Pharm; 1999 Feb; 56(3):203. PubMed ID: 10030499
    [No Abstract]   [Full Text] [Related]  

  • 26. FDA's Rx for better medication information.
    Farley D
    FDA Consum; 1995 Nov; 29(9):5-10. PubMed ID: 10152787
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Evaluation of FDA safety-related drug label changes in 2010.
    Lester J; Neyarapally GA; Lipowski E; Graham CF; Hall M; Dal Pan G
    Pharmacoepidemiol Drug Saf; 2013 Mar; 22(3):302-5. PubMed ID: 23280652
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Off-label drug use.
    Dooley AG
    Med Health R I; 2007 Feb; 90(2):63-5. PubMed ID: 17500258
    [No Abstract]   [Full Text] [Related]  

  • 29. FDA requires boxed warning for all immediate-release opioid products.
    Thompson CA
    Am J Health Syst Pharm; 2016 May; 73(9):e114-5. PubMed ID: 27099322
    [No Abstract]   [Full Text] [Related]  

  • 30. Patient package inserts: the proper prescription?
    Rowe HM
    Food Drug Law J; 1995; 50(1):95-124. PubMed ID: 10342988
    [No Abstract]   [Full Text] [Related]  

  • 31. Off-label prescribing. Legal implications.
    Henry V
    J Leg Med; 1999 Sep; 20(3):365-83. PubMed ID: 10530051
    [No Abstract]   [Full Text] [Related]  

  • 32. Consistency in the safety labeling of bioequivalent medications.
    Duke J; Friedlin J; Li X
    Pharmacoepidemiol Drug Saf; 2013 Mar; 22(3):294-301. PubMed ID: 23042584
    [TBL] [Abstract][Full Text] [Related]  

  • 33. FDA proposes new rules for off-label use of prescription drugs. Food and Drug Administration.
    Baker R
    BETA; 1998 Jul; ():8-9. PubMed ID: 11365570
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [The influence of the drug legislation on drug information for the physician and patient].
    Schwabe U
    Internist (Berl); 1980 Jun; 21(6):311-7. PubMed ID: 7005167
    [No Abstract]   [Full Text] [Related]  

  • 35. Summaries of safety labeling changes approved by FDA-Boxed warnings highlights October-December 2015.
    Office of Health & Constituent Affairs U.S. Food and Drug Administration
    Am J Health Syst Pharm; 2016 Mar; 73(5):267. PubMed ID: 26896495
    [No Abstract]   [Full Text] [Related]  

  • 36. Communicating with patients about their medications.
    Kessler DA
    N Engl J Med; 1991 Dec; 325(23):1650-2. PubMed ID: 1944456
    [No Abstract]   [Full Text] [Related]  

  • 37. Warfarin interactions with substances listed in drug information compendia and in the FDA-approved label for warfarin sodium.
    Anthony M; Romero K; Malone DC; Hines LE; Higgins L; Woosley RL
    Clin Pharmacol Ther; 2009 Oct; 86(4):425-9. PubMed ID: 19587643
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Surprises of off-label drug use--where had all the prostin gone?
    De Decker R; Gordon-Graham E; Seller N; Lawrenson J
    S Afr Med J; 2009 Jun; 99(6):432-4. PubMed ID: 19736841
    [No Abstract]   [Full Text] [Related]  

  • 39. Is it a cosmetic, a drug, or both? (Or is it soap?).
    Center for Safety and Applied Nutrition/Office of Cosmetics and Colors US Food and Drug Administration
    Plast Surg Nurs; 2008; 28(4):195-7. PubMed ID: 19092587
    [No Abstract]   [Full Text] [Related]  

  • 40. Warning signs.
    Nature; 2008 Mar; 452(7185):254. PubMed ID: 18354433
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.